Search research articles
Contact Us
Filters
Showing results (21-30 of 75) with videos related to
Page
of 8
Sort By:
The Open Ophthalmology Journal
|
March 26, 2016
Coats' Disease: Very Long-Term Outcome After Early Stage Conventional Treatment
Salvatore Perrone, Alberto Rossetti, Patrick Sportiello, et al.
Journal of Clinical Medicine
|
December 30, 2025
How to Read a Next-Generation Sequencing Report for AML and MDS? What Hematologists Need to Know
Salvatore Perrone, Cristina Tresoldi, Silvia Rigamonti, et al.
Cancers
|
January 11, 2024
Venetoclax: A Game Changer in the Treatment of Younger AML Patients?
Matteo Molica, Salvatore Perrone, Vincenzo Federico, et al.
Cancers
|
June 24, 2022
CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML
Matteo Molica, Salvatore Perrone, Carla Mazzone, et al.
Ejhaem
|
July 18, 2022
Unexpected cause of pancytopenia in a teenager with Noonan syndrome
Salvatore Perrone, Natalia Cenfra, Federica Viola, et al.
Cancers
|
June 22, 2023
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond
Salvatore Perrone, Paolo Lopedote, Vitaliana De Sanctis, et al.
Cancers
|
July 2, 2021
CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin
Matteo Molica, Salvatore Perrone, Carla Mazzone, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
July 10, 2024
Is There a Better Therapeutic Time Window from Diagnosis to Treatment for Elderly Acute Myeloid Leukemia Patients Receiving Hypomethylating Agents?
Matteo Molica, Luca Maurillo, Marco Rossi, et al.
Chemotherapy
|
March 7, 2021
Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life
Pierantonio Menna, Emanuela Salvatorelli, Maria Ilaria Del Principe, et al.
Leukemia Research
|
April 1, 2016
Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era
Salvatore Perrone, Gianna Maria D'Elia, Giorgia Annechini, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 75) with videos related to
Sort By:
Page
of 8
The Open Ophthalmology Journal
|
March 26, 2016
Coats' Disease: Very Long-Term Outcome After Early Stage Conventional Treatment
Salvatore Perrone, Alberto Rossetti, Patrick Sportiello, et al.
Journal of Clinical Medicine
|
December 30, 2025
How to Read a Next-Generation Sequencing Report for AML and MDS? What Hematologists Need to Know
Salvatore Perrone, Cristina Tresoldi, Silvia Rigamonti, et al.
Cancers
|
January 11, 2024
Venetoclax: A Game Changer in the Treatment of Younger AML Patients?
Matteo Molica, Salvatore Perrone, Vincenzo Federico, et al.
Cancers
|
June 24, 2022
CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML
Matteo Molica, Salvatore Perrone, Carla Mazzone, et al.
Ejhaem
|
July 18, 2022
Unexpected cause of pancytopenia in a teenager with Noonan syndrome
Salvatore Perrone, Natalia Cenfra, Federica Viola, et al.
Cancers
|
June 22, 2023
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond
Salvatore Perrone, Paolo Lopedote, Vitaliana De Sanctis, et al.
Cancers
|
July 2, 2021
CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin
Matteo Molica, Salvatore Perrone, Carla Mazzone, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
July 10, 2024
Is There a Better Therapeutic Time Window from Diagnosis to Treatment for Elderly Acute Myeloid Leukemia Patients Receiving Hypomethylating Agents?
Matteo Molica, Luca Maurillo, Marco Rossi, et al.
Chemotherapy
|
March 7, 2021
Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life
Pierantonio Menna, Emanuela Salvatorelli, Maria Ilaria Del Principe, et al.
Leukemia Research
|
April 1, 2016
Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era
Salvatore Perrone, Gianna Maria D'Elia, Giorgia Annechini, et al.
Page
of 8